Anti-CXCL12 antibody molecules and their uses
US10647766B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2015 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Apr 23, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/66
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-CXCL12 antibody molecules and their uses are disclosed, and in particular anti-CXCL12 antibody molecules that are capable of inhibiting a biological activity of CXCL12 in vitro and in vivo and their use for treating CXCL12-mediated disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.